1991
DOI: 10.1016/0002-9149(91)90944-g
|View full text |Cite
|
Sign up to set email alerts
|

Update of effects of calcium antagonists in myocardial infarction or angina in light of the second danish verapamil infarction trial (DAVIT-II) and other recent studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
56
1
14

Year Published

1993
1993
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 250 publications
(74 citation statements)
references
References 7 publications
3
56
1
14
Order By: Relevance
“…These classes of antihypertensives have shown cardioprotective [12][13][14][15][16] and nephroprotective 17,18 effects as well as lack of adverse metabolic effects. A combination of these classes may potentially offer benefits over other combined regimens.…”
Section: Journal Of Human Hypertensionmentioning
confidence: 99%
“…These classes of antihypertensives have shown cardioprotective [12][13][14][15][16] and nephroprotective 17,18 effects as well as lack of adverse metabolic effects. A combination of these classes may potentially offer benefits over other combined regimens.…”
Section: Journal Of Human Hypertensionmentioning
confidence: 99%
“…Tais ações deletérias foram observadas com todas as classes de antagonistas do cálcio testadas com essa indicação [243][244][245] . Por outro lado, existem evidências de que, em casos de infarto do miocárdio sem supradesnível do segmento ST, o diltiazem e o verapamil podem ter efeito protetor 246,247 .…”
Section: -Bloqueadores Dos Canais De Cálciounclassified
“…49 Nondihydropyridine CCB (diltiazem, verapamil) can also lower the heart rate, may reduce the rate of reinfarction and increase the patient survival after an AMI. 66 In the kidney, dihydropyridine CCB appear to dilate the preglomerular afferent arteriole, 67 which allows more of the systemic pressure to be translated to the glomerulus. Despite the reduction in systemic pressure by dihydropyridine CCB, the intraglomerular pressure may not be changed or even elevated.…”
Section: Diureticsmentioning
confidence: 99%